2023
DOI: 10.3389/fendo.2023.1146955
|View full text |Cite
|
Sign up to set email alerts
|

Cinacalcet use in secondary hyperparathyroidism: a machine learning-based systematic review

Abstract: IntroductionThis study aimed to systematically review research on cinacalcet and secondary hyperparathyroidism (SHPT) using machine learning-based statistical analyses.MethodsPublications indexed in the Web of Science Core Collection database on Cinacalcet and SHPT published between 2000 and 2022 were retrieved. The R package “Bibliometrix,” VOSviewer, CiteSpace, meta, and latent Dirichlet allocation (LDA) in Python were used to generate bibliometric and meta-analytical results.ResultsA total of 959 articles w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 53 publications
0
1
0
Order By: Relevance
“…Cinacalcet also reduces serum calcium and phosphate levels by blocking the mobilization of calcium and phosphate from bone due to PTH suppression. Gastrointestinal symptoms such as nausea and vomiting are common adverse effects of cinacalcet use, in addition to hypocalcemia [44].…”
Section: Treatmentmentioning
confidence: 99%

Secondary hyperparathyroidism: Update

Erick Alexander Cabrera Estrada,
Epitafio Rafael Mestre Sequeda,
Iván Alberto Salas Pinzón
et al. 2024
World J. Adv. Res. Rev.
“…Cinacalcet also reduces serum calcium and phosphate levels by blocking the mobilization of calcium and phosphate from bone due to PTH suppression. Gastrointestinal symptoms such as nausea and vomiting are common adverse effects of cinacalcet use, in addition to hypocalcemia [44].…”
Section: Treatmentmentioning
confidence: 99%

Secondary hyperparathyroidism: Update

Erick Alexander Cabrera Estrada,
Epitafio Rafael Mestre Sequeda,
Iván Alberto Salas Pinzón
et al. 2024
World J. Adv. Res. Rev.